Annual Total Liabilities
$12.19 M
-$274.10 K-2.20%
December 31, 2023
Summary
- As of February 26, 2025, RLMD annual total liabilities is $12.19 million, with the most recent change of -$274.10 thousand (-2.20%) on December 31, 2023.
- During the last 3 years, RLMD annual total liabilities has fallen by -$408.70 thousand (-3.24%).
- RLMD annual total liabilities is now -54.62% below its all-time high of $26.87 million, reached on June 30, 2014.
Performance
RLMD Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$8.10 M
-$1.44 M-15.07%
September 30, 2024
Summary
- As of February 26, 2025, RLMD quarterly total liabilities is $8.10 million, with the most recent change of -$1.44 million (-15.07%) on September 30, 2024.
- Over the past year, RLMD quarterly total liabilities has dropped by -$4.26 million (-34.48%).
- RLMD quarterly total liabilities is now -83.32% below its all-time high of $48.57 million, reached on September 30, 2014.
Performance
RLMD Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RLMD Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.2% | -34.5% |
| 3 y3 years | -3.2% | -55.6% |
| 5 y5 years | +367.9% | +219.3% |
RLMD Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.0% | at low | -61.0% | at low |
| 5 y | 5-year | -19.0% | +736.5% | -61.0% | +258.2% |
| alltime | all time | -54.6% | >+9999.0% | -83.3% | >+9999.0% |
Relmada Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.10 M(-15.1%) |
| Jun 2024 | - | $9.54 M(-22.9%) |
| Mar 2024 | - | $12.36 M(+1.4%) |
| Dec 2023 | $12.19 M(-2.2%) | $12.19 M(+44.8%) |
| Sep 2023 | - | $8.42 M(-21.3%) |
| Jun 2023 | - | $10.70 M(+6.0%) |
| Mar 2023 | - | $10.10 M(-19.0%) |
| Dec 2022 | $12.47 M(-17.2%) | $12.47 M(-40.0%) |
| Sep 2022 | - | $20.78 M(+9.8%) |
| Jun 2022 | - | $18.92 M(+22.8%) |
| Mar 2022 | - | $15.41 M(+2.3%) |
| Dec 2021 | $15.06 M(+19.5%) | $15.06 M(-17.5%) |
| Sep 2021 | - | $18.25 M(+31.1%) |
| Jun 2021 | - | $13.92 M(+9.4%) |
| Mar 2021 | - | $12.72 M(+0.9%) |
| Dec 2020 | $12.60 M(+764.6%) | $12.60 M(+271.8%) |
| Sep 2020 | - | $3.39 M(+45.7%) |
| Jun 2020 | - | $2.33 M(+2.9%) |
| Mar 2020 | - | $2.26 M(-10.9%) |
| Dec 2019 | $1.46 M(-44.1%) | - |
| Sep 2019 | - | $2.54 M(-2.7%) |
| Jun 2019 | $2.61 M | $2.61 M(+22.4%) |
| Mar 2019 | - | $2.13 M(+14.2%) |
| Dec 2018 | - | $1.86 M(-81.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | $10.30 M(+20.3%) |
| Jun 2018 | $8.56 M(+521.9%) | $8.56 M(+20.4%) |
| Mar 2018 | - | $7.11 M(+21.5%) |
| Dec 2017 | - | $5.85 M(+41.1%) |
| Sep 2017 | - | $4.15 M(+201.4%) |
| Jun 2017 | $1.38 M(-57.0%) | $1.38 M(+0.6%) |
| Mar 2017 | - | $1.37 M(-11.7%) |
| Dec 2016 | - | $1.55 M(-34.0%) |
| Sep 2016 | - | $2.35 M(-26.7%) |
| Jun 2016 | $3.20 M(-79.5%) | $3.20 M(+27.4%) |
| Mar 2016 | - | $2.51 M(-48.1%) |
| Dec 2015 | - | $4.84 M(-27.2%) |
| Sep 2015 | - | $6.65 M(-57.3%) |
| Jun 2015 | $15.58 M(-42.0%) | $15.58 M(-38.5%) |
| Mar 2015 | - | $25.36 M(-10.1%) |
| Dec 2014 | - | $28.20 M(-41.9%) |
| Sep 2014 | - | $48.57 M(>+9900.0%) |
| Jun 2014 | $26.87 M(>+9900.0%) | - |
| Feb 2014 | - | $41.20 K(+2.2%) |
| Nov 2013 | - | $40.30 K(+19.6%) |
| Aug 2013 | $33.70 K(+381.4%) | $33.70 K(+29.6%) |
| May 2013 | - | $26.00 K(+116.7%) |
| Feb 2013 | - | $12.00 K(+71.4%) |
| Aug 2012 | $7000.00 | $7000.00 |
FAQ
- What is Relmada Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Relmada Therapeutics?
- What is Relmada Therapeutics annual total liabilities year-on-year change?
- What is Relmada Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Relmada Therapeutics?
- What is Relmada Therapeutics quarterly total liabilities year-on-year change?
What is Relmada Therapeutics annual total liabilities?
The current annual total liabilities of RLMD is $12.19 M
What is the all time high annual total liabilities for Relmada Therapeutics?
Relmada Therapeutics all-time high annual total liabilities is $26.87 M
What is Relmada Therapeutics annual total liabilities year-on-year change?
Over the past year, RLMD annual total liabilities has changed by -$274.10 K (-2.20%)
What is Relmada Therapeutics quarterly total liabilities?
The current quarterly total liabilities of RLMD is $8.10 M
What is the all time high quarterly total liabilities for Relmada Therapeutics?
Relmada Therapeutics all-time high quarterly total liabilities is $48.57 M
What is Relmada Therapeutics quarterly total liabilities year-on-year change?
Over the past year, RLMD quarterly total liabilities has changed by -$4.26 M (-34.48%)